220例腹水型晚期血吸虫病患者临床路径救治效果

目的 目的 评价腹水型晚期血吸虫病 （晚血） 临床路径的救治效果。方法 方法 根据 《血吸虫病防治手册》、《湖北省晚期血吸虫病临床路径》 管理方案， 分别采用传统路径和临床路径方法对洪湖市2013年和2014年各220例晚血患者进行治疗， 比较患者平均住院日、 疾病知晓率、 患者满意度和平均费用等指标， 分析临床路径管理在腹水型晚血病人治疗中的效果。结果 结果 采用临床路径治疗的患者在病情转归无明显差异的情况下， 平均住院日由14 d下降到12 d， 平均治疗费用由6 400元下降到5 800元， 患者的疾病知晓率和满意度均提高到95%， 与传统路径组相比， 差异均具有统计学意义 （P均<0.05）。结论 结论 采用临床路径治疗晚血能规范医疗行为， 避免医疗资源的浪费， 值得推广应用。

Effect of clinical pathway on advanced schistosomiasis patients with acites: a report of 220 cases

Objective Objective To evaluate the effect of the clinical pathway on advanced schistosomiasis patients with acites. Meth Meth? ?ods ods According to the Handbook of Schistosomiasis Control，and the Clinical Pathway on Advanced Schistosomiasis in HubeiProvince，the therapeutic effects，disease awareness，and the satisfaction of patients of 220 advanced schistosomiasis patients（ascitic type）who were treated by the traditional pathway in 2013 and 220 patients who treated by the clinical pathway in 2014，respectively，were evaluated and compared with the statistical method. Results Results As the outcomes of the patients had no signifi?cant difference between the traditional pathway therapy and the clinical pathway therapy，the average hospitalization days andmedical expense were reduced when the patients were treated by the clinical pathway. The average hospitalization days were re?duced to 12 days from 14 days. The average medical expense was reduced to RMB 5 800 form RMB 6 400. The average rate ofawareness about the disease and the satisfaction rate of the patients were raised to 95% in the patients treated by the clinicalpathway. The results of t test for the three indicators above mentioned showed significant differences between the two therapies（all P < 0.05） . Conclusion Conclusion The clinical pathway can standardize the medical behavior and avoid the waste of medical resourc?es，so as to improve the treatment of advanced schistosomiasis.